Robert Balog, PhD profile page

Dr. Robert Balog leads Thermo Fisher Scientific’s Microarray R&D team, responsible for developing next-generation Microarray hardware, software and assay workflows to support the clinical and research genomics markets. Prior to his current role, he led the clinical system engineering team responsible for Thermo Fisher’s Amplitude High Throughput SARS-CoV-2 testing platform. Robert has over 15 years of experience in product development, from basic biomarker discovery to on-market support of diagnostic testing systems in both genomics and proteomics. Prior to Thermo Fisher, he spent 3 years as CEO and cofounder of BioCeryx, developing automated microfluidic devices for noninvasive prenatal testing and 14 years as a Program Director at SRI International, developing host response IVDs for radiation exposure and integrated nucleic acid analysis systems. Dr. Balog has a PhD in biomedical engineering from the University of Texas, Southwestern Medical Center at Dallas and a BE in molecular biology and biomedical engineering from Vanderbilt University.